
    
      Patients with IgG4-RD will be randomized in two therapeutic groups: Prednisone alone and
      combination therapy with Prednisone and Mycophenolate mofetil. These patients will be
      followed in 12 months. Treatment response and relapse will be recorded, as well as side
      effects.
    
  